Essity

Transaction in Own Shares • May 19, 2025

Press release

Stockholm, May 19, 2025

Buyback of Class B shares in Essity during week 20, 2025

Between May 12, 2025, and May 16, 2025, Essity Aktiebolag (publ) repurchased a total of 268,866 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

Date	Aggregated daily volume (no. of shares):	Weighted average price per day (SEK):	Total daily transaction value (SEK):
May 12, 2025	51,908	274.8483	14,266,826
May 13, 2025	52,206	274.4259	14,326,679
May 14, 2025	62,351	270.9193	16,892,089
May 15, 2025	50,832	273.9087	13,923,327
May 16, 2025	51,569	277.3013	14,300,151
Total accumulated during week 20 2025	268,866	274.1480	73,709,071
Total accumulated during the buyback program	838,922	274.6050	230,372,203

Class B shares in Essity were repurchased as follows:

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on May 16, 2025, to 1,621,422 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,973,654 Class A shares and 634,080,835 Class B shares.

For additional information, please contact: Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.